Hepatitis viruses in Ethiopia: a systematic review and meta-analysis

BMC Infectious Diseases

Table 4 Magnitude of HCV antibody prevalence among different study population in different regions of Ethiopia from 1988 to 2014

Study group	Sampling year	Study area	Study population	Anti-HCV Ab frequency (%)	References
Community based	1993	A.Ababa & its outskirts	1580	32 (2.0)	[56]
	1994	A.Ababa	2663	29 (0.8)	[55]
	2002	Kemissie & Omo	5248	68 (1.3)	[28]
Blood donors	1995	A.Ababa	500	7 (1.4)	[49]
	2003	North Ethiopia	600	10 (1.7)	[57]
	2004	Gondar	600	35 (5.8)	[9]
	2006	Bahirdar	324	43 (13.3)	[8]
	2007	Gondar	6361	35 (0.7)	[17]
	2008	Bahir Dar	2384	15 (0.6)	[13]
	2010	Jimma	6063	12 (0.2)	[15]
Symptomatic liver disease patients	1988	North Ethiopia	139	20 (14.0)	[47]
	1992	A.Ababa	110	21 (19.0)	[48]
	1995	A.Ababa	238	90 (37.8)	[49]
	2011	A. Ababa	120	27 (22.5)	[44]
	2011	Gondar	2684	322 (12.0)	[50]
	2013	Bale Robe	220	6 (2.7)	[51]
HIV infected individuals	1994	A. Ababa	165	8(4.8)	[55]
	2006	A. Ababa	734	50 (6.8)	[66]
	2008	Hawassa	400	42(10.5)	[11]
	2011	A. Ababa	500	18 (3.6)	[53]
	2011	Mekele	174	16(9.2)	[12]
	2012	D/ Tabour	395	5(1.3)	[67]
	2013	A.Ababa	387	25(6.5)	[68]
	2013	Gondar	400	22(5.5)	[64]
	2013	Bahirdar	269	59(21.9)^a	[100]
	2014	Bahirdar	253	14(5.5)	[69]
Others^b	2006	Gondar	480	6 (1.3)	[39]
	2006	A. Ababa	1220	21 (1.7)	[66]
	2008	Hawassa	400	24(6.0)	[11]
	2010	Jimma	304	30 (9.9)	[58]
	2010	Jimma	300	10 (3.3)	[58]
	2010	Gamo HP	556	1 (0.2)	[33]
	2011	Gondar	200	2 (1.0)	[32]
	2011	Mekele	126	2 (1.6)	[12]
	2012	D/ Markos	423	6 (1.4)	[10]

^aReported as 18.9% in the original work, but the 3.0% anti-HCV antibody reported as co-infected with HBsAg was summed up and became 21.9%
^bIncludes antenatal care attendants, HIV voluntary counselling and testing (VCT) clients (HIV negative), VCT clients, diabetic patients, non-diabetic patients (controls for diabetic patients), out and inpatient department clients, healthcare workers and medical waste handlers, and VCT clients

ISSN: 1471-2334